Smart Contact Lens Helps Predict Disease Progression in Glaucoma Patients

ByConnor Hodde

A contact lens with a built-in sensor could help determine which glaucoma patients have a higher risk of disease progression, according to a new study.  Glaucoma remains a leading cause of blindness. One of the main indicators of the disease is high pressure in the eye, or intraocular pressure.  Researchers at Columbia tested the lenses on…

Aerie Pharmaceuticals Reports Positive Rhopressa™ Phase 3 Efficacy Results

ByConnor Hodde

Aerie Pharmaceuticals, a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its second Phase 3 trial for Rhopressa™, a novel once-daily, triple-action eye drop being tested for its ability to lower intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. Read the entire…